Chronic liver disease and cirrhosis among patients with hepatitis B virus infection in northern Portugal with reference to the viral genotypes. by Mota, A. et al.
Journal of Medical Virology 83:71–77 (2011)
Chronic Liver Disease and Cirrhosis Among Patients
With Hepatitis B Virus Infection in Northern
Portugal With Reference to the Viral Genotypes
Ana Mota,1,2 Jorge Areias,1,3 and Margarida Fonseca Cardoso1,4,5*
1ICBAS Abel Salazar Biomedical Institute, University of Porto, Porto, Portugal
2Clinical Hematology Service, Santo Anto´nio Hospital (HSA), Porto, Portugal
3Gastroenterology Service, Santo Anto´nio Hospital (HSA), Porto, Portugal
4CIIMAR—Center of Marine and Environmental Research, Porto, Portugal
5ISPUP—Institute of Public Health, University of Porto, Porto, Portugal
The prevalence of infection with hepatitis B virus
in Portugal is around 1% of the population; 20–
30% of those infected typically develop cirrhosis.
The study focuses on the epidemiological proﬁle
of patients with hepatitis B infection and liver
damage, in particular, cirrhosis. Of the 358
individuals that comprised the study, a liver
biopsy was performed in 249 to identify the
presence of cirrhosis. Cirrhosis was observed in
59 patients (23.7%) TheChild–Pugh classiﬁcation
was used to assess the prognosis of cirrhosis: 3
out of the 59 patients were classiﬁed as Child–
Pugh grade C, the most severe, 17 (28.8%) as
grade B, and 39 (66.2%) as grade A. Patients
classiﬁed as grade B were older, drank more,
and showed higher levels of AST and alkaline
phosphatase when compared with individuals
classiﬁed as grade A. Genotypes A and D were
predominant, and no signiﬁcant differences with
respect to genotype distribution were observed.
Analysis of the hematological parameters
showed that patients classiﬁed as Child’s grade
Bhad lower levels of platelets andhigher levels of
prothrombin time than those classiﬁed as Child’s
grade A. The proﬁle of the patientswith cirrhosis,
including an extended number of individual
characteristics, provides useful information,
however, only a prospective study could evaluate
deﬁnitively if liver disease is inﬂuenced by these
factors. Future studies would beneﬁt from the
analysis of the impact of genotypes on liver
disease, particularly genotypesAandD, themost
predominant genotypes in northern Portugal.
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INTRODUCTION
Cirrhosis occurs in 20–30% of those patients who are
infected chronically with the hepatitis B virus (HBV).
About 25% of these may develop hepatocellular carci-
noma (HCC). In patients with chronic HBV and HCC,
the genetic material of HBV is frequently found to be
part of the genetic material of the cancer cells. TheHBV
genetic material enters the normal liver cells and
disrupts their function, and may lead to transformation
into cancerous cells. Because of the genetic mutation
caused by HBV, a patient with HBV infection may
develop HCC with or without cirrhosis.
Persistent hepatitis B infection affects 350–400mil-
lion people worldwide [Lee, 1997; Yuen et al., 2009].
These patients are at least 100 times more likely to
develop HCC compared with uninfected individuals
[Beasley et al., 1981]. HCC is the leading cause of death
in patients with cirrhosis [Varela et al., 2010]. Several
potential factors have been linked with a higher risk of
developing HCC, including male gender, advanced age,
virological factors such as hepatitis B e antigen (HBeAg)
positivity and high serum HBV DNA levels [Sherman,
2005].
The association between HBV genotypes and severity
of liver disease remains debatable, although one study
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has foundmoreﬁbrosis in patientswith genotypeA than
with genotype D [Halfon et al., 2006].
Portugal is populated by approximately 10million
inhabitants, with an immigrant community of around
4%. Immigrants are concentrated in the South with an
epicentre in Lisbon while the North of the country has
relatively fewer immigrants [MAI, 2008]. At present,
there is no information on the prevalence of HBV
infection in Portugal. According to the most representa-
tive research in this ﬁeld, patients chronically infected
with HBV comprise approximately 0.36–1% of the
Portuguese population [Lecour et al., 1984; Santos
et al., 2000; Ministe´rio da Sau´de, 2004].
The results of the study are part of a project in
progress at a Portuguese university to characterize the
epidemiological proﬁle of the HBV in northern Portugal
[Mota et al., 2009, 2010]. This study, within the ambit of
a larger project, focuses on the epidemiological proﬁle of
liver damage, particularly cirrhosis, in patients infected
chronically with HBV.
MATERIALS AND METHODS
Study Design
Data were obtained as part of an epidemiological
study of the HBV in northern Portugal [Mota et al.,
2009]. From a group of 358 individuals with chronic
HBV infection, serum samples were tested for HBsAg,
antibodies to HBsAg (anti-HBs), antibodies to the HBV
core antigen (anti-HBc), HBeAg, and antibodies to
HBeAg (anti-HBe). HBV genotypes were determined
along with other biochemical and hematological param-
eters. The present study includes the 249 patients who
underwent histological evaluation.
Patients
Patients with hepatitis B infection were identiﬁed by
the presence of HBsAg in their serum for at least
6 months. The majority of patients from the North of
Portugal, are treated in three hospitals in the city of
Oporto: Hospital de Santo Anto´nio, Hospital Joaquim
Urbano and Hospital de Sa˜o Joa˜o. The patients in this
study were examined in 2008 and 2009 in the Hospital
de Santo Anto´nio and Hospital Joaquim Urbano. The
study was approved by the Health Ethics Committee of
Hospital de Santo Anto´nio, and written consent was
obtained from all participants.
Clinical Findings
Information related to the demographics, clinical,
histological, and medical history of the patients was
retrieved from medical ﬁles.
Biochemical Tests of Liver Function and Other
Blood Parameters
The blood tests considered when assessing liver
function included: alanine aminotransferase (ALT,
reference values 10–36U/L at 378C) and aspartate
aminotransferase (AST, reference values 10–30U/L at
378C), which are contained within liver cells, gamma-
glutamyltranspeptidase (GGT, reference values 10–
66U/L at 378C), alkaline phosphatase (AP, reference
values 45–122U/L at 378C), and alpha-fetoprotein
(AFP, reference values <10.9 ng/ml). Hematological
parameters like mean corpuscular volume (MCV), and
plateletswerealso evaluatedusinganAdvia120System
(Bayer, Tarrytown, New York). Prothrombin time (PT)
measurementwas performedusing anACLTOP system
(Instrumentation Laboratory Company, Lexington,
MA).
Detection of Virological Markers in Serum
HBsAg, anti-HBs and anti-HBc, HBeAg, and anti-
HBe antibodies were evaluated using a Vitros ECI
assays (Ortho-Clinical Diagnostics, Amersham, Buck-
inghamshire, UK).
HBV DNA Quantitation
HBV DNA levels were determined using the
Versant1HBV DNA 3.0 assay (bDNA; Bayer). The
assay quantitation range is 357–17,900,000 HBV
DNAIU/ml.
HBV Genotyping
HBVgenotypeswere identiﬁed by the Trugene1HBV
genotyping kit in conjunction with the Open Gene
1DNA Sequencing System (Bayer).
Cirrhosis
Cirrhosis was evaluated by liver biopsy.
Child–Pugh Classiﬁcation
This classiﬁcation was used to assess the prognosis of
cirrhosis. Child’s grading of severity in chronic liver
disease was classiﬁed along with Pugh’s [1973] mod-
iﬁcations and based upon information recorded from
medical ﬁles. The classiﬁcation has three grades, fromA
to C with grade C being the severest. The respective
overall 5-year mortality rates for grades C–A are 88%,
38%, and 29%.
Statistical Analysis
Statistical analysis was performed with SPSS
(version 16.0) and two-sided signiﬁcance tests at the
5% level were used throughout.
Qualitative variables were described as percentages
and quantitative variables as means, or geometric
means where necessary. The distribution of viral load
was logarithmically transformed and the results are
given as geometric means with 95% conﬁdence inter-
vals. For the other quantitative variables, results were
given as arithmetic means (standard deviation).
Proportions were compared using the Pearson’s
chi-squared test (with continuity correction) as appro-
priate, or by Fisher’s exact test. Continuous variables
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were comparedusing the t-test, after log-transformation
so that assumptions were met, if necessary. Multi-
variable analysis was not considered due to the reduced
number of individuals when subdivided by cirrhosis,
gender, and the Child’s grading of disease severity for
chronic liver disease.
RESULTS
Liver biopsy was performed on 249 patients for
histological assessment. Cirrhosis was found in 59
patients (23.7%).
Genders were analyzed separately, and patients with
and without cirrhosis were compared. Genotypes A and
D were predominant, and no signiﬁcant differences
between the study groups were observed with respect to
genotype distribution, in both genders (Table I). The
distribution of the presumed sources of transmission of
viral infection was similar among female patients,
while sexual transmission was an increased factor in
male patients with cirrhosis (P¼ 0.013). Alcohol intake
levels (less or more than 20 g/day) were similar between
the two groups with or without cirrhosis. On average,
male patients with cirrhosis were older than patients
without cirrhosis (P¼0.001), while the same was
true with female patients the relationship was not
signiﬁcant.
In patients with cirrhosis, liver disease severity was
evaluated using Child’s grading of disease severity with
Pugh’s modiﬁcations (Table II).
Evaluation of the 59 patients, 32.2% female, was
carried out according to the Child–Pugh classiﬁcation.
In the female group, Child’s grade A classiﬁcation was
the most frequent (78.9%) and only one woman was
classiﬁed as Child´s grade C. On the other hand, an
increased proportion of Child’s grade B classiﬁcation
was observed in men (35% vs. 15.8% in women) while
two were classiﬁed as Child’s grade C.
Child’s Grade Equivalent C
Only three patients scored sufﬁciently to receive a
Child–Pugh classiﬁcation level C, two of them being
male. All patients were genotype D, and aged between
66- and 80-year old. The presumed source of infection is
unknown in two patients while the third patient had a
reported intrafamilial transmission of HBV infection.
All patients (n¼3) were HBeAg negative, and all of
them also presented viral load of HBV >357-HBV
DNAIU/ml.
TABLE I. Characteristics of Patients With and Without Cirrhosis
Without cirrhosis (n¼ 190) With cirrhosis (n¼ 59)
P-valuena % na %
Female
Genotype 0.554c
A 20/83 24.1 7/19 36.8
D 55/83 66.3 12/19 63.2
E 4/83 4.8 0/19 0.0
F 4/83 4.8 0/19 0.0
D and F 0/83 0.0 0/19 0.0
Presumed source of HBV
infection
d
Perinatal 20/83 24.1 4/19 21.1
Sexual 13/83 15.7 2/19 10.5
Intrafamilial 29/83 34.9 6/19 31.6
Othersb 21/83 25.3 7/19 36.8
Alcohol intake >20 g/day 25/70 35.7 6/18 33.3 0.850
Mean age (SD) 44.1 12.9 48.5 19.1 0.354
Male
Genotype 0.742c
A 37/107 34.6 13/40 32.5
D 60/107 56.1 26/40 65.0
E 6/107 2.8 0/40 0.0
F 3/107 2.8 1/40 2.5
D and F 1/107 0.9 0/0 0.0
Presumed source of HBV
infection
0.013
Perinatal 29/107 27.1 3/40 7.5
Sexual 13/107 12.1 12/40 30.0
Intrafamilial 23/107 21.5 10/40 25.0
Othersb 42/107 39.3 15/40 37.5
Alcohol intake >20 g/day 53/96 55.2 21/37 61.8 0.872
Mean age (SD)c 41.5 13.9 50.8 15.9 0.001
aTotal for each variable may not sum to the sample size due to missing data.
bOther sources, including at least one incidence of intravenous drug use, blood transfusion, occupational exposure, iatrogenic exposure (e.g.,
endoscopy or coloscopy, history of surgery, acupuncture, or hemodialysis), or unknown.
cEvaluated only for genotypes A and D.
dThe necessary statistical assumptions were not met.
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Biochemical tests revealed ALT was elevated in two
individuals, AST in all three, while only one occurrence
of elevated AP, GGT, and AFP was found.
Child’s Grade Equivalent A and B
Individuals classiﬁedasChild’s gradeA (n¼39) andB
(n¼ 17) were compared by gender, genotype, the
presumed source of infection, alcohol intake, place of
birth, age, viral markers, viral load, and biochemistry
parameters (Table III).
When patients with cirrhosis, were compared by
gender, genotype, and the presumed source of infection,
no signiﬁcant differences between Child’s grades A and
B were found. Individuals classiﬁed as Child’s grade B
were older and had a signiﬁcantly higher proportion of
patients with alcohol intake above 20 g/day (P 0.004).
Patients classiﬁed asChild’s gradeB showed a tendency
to have higher proportions of elevated biochemistry
parameters like AST, AP, GGT, and AFP when com-
pared with individuals classiﬁed as grade A.
Hematological parameters were also compared
(Table III). Patients classiﬁed as Child’s grade B had
signiﬁcantly lower levels of platelets (P< 0.001) and
signiﬁcant higher levels of PT (P¼ 0.013) than patients
classiﬁed as Child’s grade equivalent A.
DISCUSSION
This study is one of the ﬁrst attempts to describe the
epidemiological proﬁle of liver damage, particularly
cirrhosis, in patients infected chronically with HBV in
Portugal. Both patients with and without cirrhosis
formed part of the study.
All patients in the study were from the North of
Portugal. In the sample of patients infected with HBV
J. Med. Virol. DOI 10.1002/jmv
TABLE II. Patients With Cirrhosis (n¼ 59) Classiﬁed by
Child’s Grade
Child’s grade n %
Female
A 15/19 78.9
B 3/19 15.8
C 1/19 5.3
Male
A 24/40 60.0
B 14/40 35.0
C 2/40 5.0
TABLE III. Comparison of the Characteristics of Patients With Cirrhosis Classiﬁed as Child’s Grade A and Child’s Grade B
(n¼ 56)
Characteristics
Child–Pugh A (n¼ 39) Child–Pugh B (n¼ 17)
P-valuena % na %
Gender 0.222
Female 15/39 38.5 3/17 17.6
Male 24/39 61.5 14/17 82.4
Genotypes
A 15/39 38.5 5/17 29.4 0.844c
D 24/39 61.5 11/17 64.7
F 39 0.0 1/17 5.9
Presumed source of HBV infection
Perinatal 7/39 17.9 17 0.0 c
Sexual 10/39 25.6 4/17 23.5
Intrafamilial 10/39 25.6 5/17 29.4
Othersb 12/39 30.8 8/17 47.1
Alcohol intake >20 g/day 12/36 33.3 13/16 81.2 0.004
Mean age (SD) 44.5 16.6 59.9 11.4 0.001
Viral markers
Anti-HBc positive 39/39 100.0 17/17 100.0 d
HBeAg negative 24/39 61.5 14/17 82.4 0.222
Anti-HBe positive 22/39 56.4 14/17 (82.4) 0.119
Viral load geom. mean (95% CI) 1,400,024.1 450,584.1–4,350,059.2 384,269.7 60,657.6–2,434,373.5 0.212
Biochemistry parameters greater than reference values
ALT 27/39 69.2 10/17 58.8 0.653
AST 23/39 59.0 15/17 88.2 0.065
AP 3/37 8.1 6/17 35.3 0.021
GGT 11/37 29.7 9/17 52.9 0.181
AFP 2/32 6.2 3/16 18.8 0.316
Hematological parameters mean (SD)
Platelet 109/L 163.3 57.8 100.1 48.2 <0.001
MCV 90.5 8.8 94.0 6.5 0.164
PT 13.2 3.0 16.1 5.5 0.013
aTotal for each variable may not sum to the sample size due to missing data.
bOther sources, including at least one incidence of intravenous drug use, blood transfusion, occupational exposure, iatrogenic exposure (e.g.,
endoscopy or coloscopy, history of surgery, acupuncture or hemodialysis), or unknown.
cEvaluated only with genotypes A and D.
dThe necessary statistical assumptions were not met.
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who underwent histological evaluation (n¼249) the
results showed that therewas a considerable proportion
with an increased incidence of liver damage, while
23.7% of the patients had cirrhosis. Genotypes A and D
were predominant in patients with or without cirrhosis.
A previous study in the North of Portugal [Mota et al.,
2009] found genotypes A and D to be predominant, with
genotype D accounting for 60.1% and genotype A
accounting for 30.1%of thepatients evaluated. InSpain,
the only country that borders Portugal, genotypes A and
D have been also found to be prevalent [Echevarria and
Leon, 2004; Basaras et al., 2007], although the relation-
ship with the stage of cirrhosis is undocumented. A
study in India found that genotype D was associated
with more severe liver diseases when compared with
genotype A. Genotype D was more prevalent in HCC
patients less than 40 years of age, when compared with
asymptomatic carriers [Thakur et al., 2002]. Similar
results are likely to be found in the North of Portugal,
given a suitably large sample size.
In this study, a statistical association was not found
between cirrhosis and genotypes of HBV (P 0.554), or
alcohol consumption level (P0.850), for bothmale and
female patients. Comparison between patients without
and with cirrhosis showed a tendency for patients with
cirrhosis to be older. Recent studies have shown that,
older age,male gender, and cirrhosiswere themajor risk
factors associated with the development of HCC [Lok,
2009].
In this study a classiﬁcation system developed to
assess the severity of liver cirrhosis, the Child–Pugh
grade, was chosen to evaluate patients. In the study
sample, 3 out of the 59 patientswere classiﬁed asChild–
Pugh grade C, the most severe, 17 (28.8%) as grade B
and 39 (66.2%) as grade A.
To understand betterwhat factors are associatedwith
the severity of liver disease those patientswith cirrhosis
classiﬁed as Child–Pugh grade B were compared with
the group classiﬁed with the less severe grade A, in
terms of HBV genotypes, patient demographics and
alcohol intake, transmission routes, virologicalmarkers
for HBV, viral load, liver enzymes, and hematological
parameters. In this study, a statistical association was
not found between severity of liver disease and gender
(P¼0.222), genotypes, (P¼ 0.844), eventual transmis-
sion routes of infection, HBeAg negativity (P¼ 0.222),
anti-HBe positive (P¼ 0.119), and viral load (P¼ 0.212).
All patients were anti-HBc positive. The analysis
showed that patients classiﬁed as Child–Pugh grade B
were older (P¼0.001) and had a signiﬁcantly higher
percentage of alcohol intake above 20 g/day (P¼ 0.004)
when compared to individuals classiﬁed as Child–Pugh
grade A. The same trend has been observed previously
when studying the relationship between the severity of
liver disease and age and alcohol consumption [Mota
et al., 2010]. While this previous study reported a
relationship between alcohol consumption and liver
disease severity, a relaxed deﬁnition of liver diseasewas
used, including patients with and without histological
evaluation, and patients without disease reports. The
present study, restricted only to patients with cirrhosis,
achieved the same positive association between age,
alcohol intake and severity of liver disease. Age and
alcohol consumption were also reported as risk factors
associated with HCC in many studies from different
countries, including Portugal [Pereira et al., 1994;
Oliveira et al., 2001; Wang et al., 2003; Chung et al.,
2007].
Hepatitis B infection may inﬂuence the development
of liver disease in heavy alcohol drinkers in several
ways. Firstly, persistent infection with HBV might
encourage alcohol-induced liver damage, and evidence
exists that this may occur at fairly low levels of alcohol
intake [Villa et al., 1982]. On the other hand, chronic
activehepatitis associatedwithHBsAgmay coexistwith
alcoholic liver disease, and the two disease processes
would probably result in more rapid progression to
cirrhosis. For this reason, a vaccination program would
be of great beneﬁt to excessive drinkers, as infection
with HBV and hepatitis C virus (HCV) are major
contributing factors towards the development of HCC
[Nalpas et al., 1998]. Alcohol-dependent patients under
treatment or attended to by emergency hospital serv-
ices, are opportunities for preventive intervention. Such
patients should be checked for viral diseases like
hepatitis C, human immunodeﬁciency virus (HIV), and
HBV infection. In all individuals without evidence of
infection with HBV, a vaccination should be imple-
mented.
The pattern observed for patientswithoutHBeAg and
viral load, in patients with chronic hepatitis B, seems to
be predominant in Mediterranean countries. Addition-
ally, some investigators have found that HBV infection
remained active after seroconversion to anti-HBe in
nearly 40% of patients [Rodriguez-Frias et al., 1995;
Grandjacques et al., 2000]. In France, an increasing
prevalence of HBeAg negative was observed [Zarski
et al., 2006], in accordance with this study of Portugal,
with probable basal promoter core or a precore region
mutations (two individuals presented anti-HBc nega-
tive). The knowledge of this characteristic is very
important for optimizing clinical management and
future therapeutic trials for chronic hepatitis B. Partic-
ularly, with respect to HBV replication status, HBV
genotype and mutations in the basal core promoter
region play an important role in the HCC development
[Lok, 2009]. Many factors seem to contribute to the
development of HCC: host and viral risk factors
associated with increased risk of cirrhosis or HCC
include older age (longer duration of infection), alcohol
consumption, smoking, HBV genotype C, high levels of
HBV DNA and concurrent infection with hepatitis-like
HCV, hepatitis D virus (HDV), or HIV [Fattovich et al.,
1995; McMahon et al., 2001; Fattovich, 2003; Yim and
Lok, 2006].
This Portuguese study showed that ALT levels in
patients with Child’s grade A and B had similar values.
On the other hand, Child’s grade B patients, showed a
higher proportion with elevated levels of AST and AP,
when compared with individuals classiﬁed as grade A.
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Even in this Portuguese study, patients classiﬁed as
Child’s grade equivalent Bhad signiﬁcantly lower levels
of platelets (P< 0.001) and signiﬁcant higher levels of
PT (P¼ 0.013) compared to the Child’s grade equivalent
A. Thrombocytopenia is considered as a valid surrogate
of cirrhosis and a valid marker for the identiﬁcation of
individuals at high-risk for HCC [Lu et al., 2006].
Although not signiﬁcant, Child’s grade B individuals
presented elevated values for GGT and AFP.
In conclusion, the present study examined the
associations between cirrhosis, and an extended num-
ber of patient’s characteristics, providing useful infor-
mation on the proﬁle of patients infected with HBV in
northern Portugal. The group of patients with cirrhosis,
classiﬁed asChild–Pugh gradeB,was older and showed
elevated levels of alcohol intake. Comparison of patients
classiﬁed as Child–Pugh grade B with individuals
classiﬁed as Child–Pugh grade A, showed a higher
proportionof biochemical parametersparticularly,AST,
AP, GGT, and elevated AFP, with hematological
parameters showing lower platelet levels and higher
PT values.
In the evaluation of cirrhosis, liver biopsy continues to
be the preferred diagnostic method, but the appearance
of ‘‘stiffness’’ measurement techniques will probably be
the eventual future diagnosis of cirrhosis. However,
additional studies are needed for the evaluation of liver
ﬁbrosis possibly based on liver ‘‘stiffness’’ measure-
ments, and cutoff values must be deﬁned for categoriz-
ing the different stages of cirrhosis.
Although no association between HBV genotypes and
severity of liver disease was observed with the sample
evaluated, it would be important in future investiga-
tions to determine the impact of genotypes on liver
disease, particularly cirrhosis.
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